PATENT CLAIM ANALYSIS

Application Number: 15775811
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "547000"]

Abstract:
The present invention provides methods for treating, controlling or mitigating hemolytic uremic syndrome (HUS), comprising administering a monoacetyldiacylglycerol compound to a patient in need thereof, as well as compositions useful therefor.

Claim (Index 11):
The method of  claim 1  wherein the HUS is triggered by a Shiga-like toxin-producing  E. coli  [e.g.,  E. coli  O157:H7].

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15775810', '14936464', '14951353', '14912920', '14959750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855519079394703
- 35 USC 102 Novelty (BERT): 0.5429049563676305
- Combined Prediction Score: 0.7612872127822863
- Mean Citation Score: 303.98119000000014
- Max Citation Score: 402.26773
- Similarity Product: 244.6631950810933

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test